Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
Feb. 28 (Bloomberg) -- Carl Icahn discusses his investment in Herbalife and the company's agreement to let him nominate two directors to its board. He speaks with Trish Regan on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
On Air Now
Max 250 characters
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC